FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine and can be used for treating or preventing bacterial diseases in a patient. For this purpose, an oxazolidinone-quinolone hybrid agent is injected parenterally. Also presented is a pharmaceutical composition, a method of treating, using the hybrid agent oxazolidinone-quinolone.
EFFECT: group of inventions provides parenteral treatment or prevention of intestinal diseases caused by gram-positive bacteria.
19 cl, 2 tbl, 2 ex
Authors
Dates
2019-10-08—Published
2014-05-09—Filed